Navigation Links
Genomatica Licenses TeselaGen Software for DNA Design
Date:7/9/2013

San Francisco and San Diego, CA (PRWEB) July 09, 2013

Genomatica and TeselaGen have signed a multi-year agreement to license TeselaGen’s software, which uses synthetic biology approaches to build and modify DNA. The two companies also will work together to enhance TeselaGen’s software to meet Genomatica’s objectives.

By using TeselaGen’s technology, Genomatica expects to accelerate development of its proprietary organisms. These organisms are an important part of the overall process technology that Genomatica delivers to its licensees for the production of major chemicals from renewable feedstocks. TeselaGen’s software provides an advanced biological computer aided design and manufacture system, with automated DNA design and assembly protocol generation.

“Genomatica’s deep expertise in microbial strain development is very valuable to TeselaGen as we develop our software to solve real problems faced by industrial biologists,” said Michael Fero, CEO, TeselaGen. “Our academic roots have given us a firm platform on which to build, but now we’re focused on meeting the needs of industrial customers working to solve very difficult practical problems. This new relationship with Genomatica is ideal from our perspective.”

“TeselaGen’s experience and capabilities in automated DNA design and cloning will be very helpful to Genomatica as we continue to advance high-throughput technologies for strain engineering,” said Mark Burk, CTO, Genomatica. “We have seen many different technologies emerging in this space, and TeselaGen brought clear, distinct and compelling value.”

About Genomatica
Genomatica is a widely-recognized technology leader for the chemical industry. It delivers new manufacturing processes that enable its licensee partners to produce the world’s most widely-used chemicals a ‘better way’ from renewable feedstocks, with better economics and greater sustainability than petroleum-based processes.

Genomatica’s first process, for BDO, is now commercial. Genomatica’s BDO process was used to make 5 million pounds of BDO in late 2012, and has been licensed by both BASF and Novamont. Multiple companies, including Toray, Lanxess and Far Eastern New Century, have confirmed that BDO produced using Genomatica’s process can be used the exact same way for downstream products as petro-chemicals, accelerating adoption. Genomatica is also developing processes for other high-volume chemicals: the next is for butadiene, with Versalis as partner.
Genomatica’s recognition includes the Wall Street Journal Technology Innovation award, ICIS Top 40 ‘Ones to Watch’, the EPA Presidential Green Chemistry Challenge Award, and being voted #1 Hottest two years in a row by Biofuels Digest.

About TeselaGen
TeselaGen is a new venture in synthetic biology housed at the QB3 incubator at UCSF. TeselaGen is building a "Design to DNA" fully automated system for designing and building complex DNA molecules and combinatorial DNA libraries. The system constitutes a rapid prototyping system for biology enabling companies to build better biologic drugs to cure disease, and more sustainable chemicals and biofuels to reduce dependence on fossil fuels.

TeselaGen’s first offering is a “software as a service” computer aided design tool to help companies design complex protocols for the assembly of DNA libraries. Future plans, supported by the National Science Foundation, include integration of the assembler output with automation for building DNA libraries of arbitrary length and complexity without human intervention.

TeselaGen’s recognition includes a Bio-IT World Best Practices Award in 2013.

Read the full story at http://www.prweb.com/releases/teselagen/genomatica/prweb10905592.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
2. Genomatica and DuPont Tate & Lyle Bio Products Successfully Produce 1,4-Butanediol (BDO) on Commercial Scale
3. HistoRx Licenses Melanoma Assay from Yale University
4. Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
5. Two Blades Foundation licenses genome engineering technology to KWS
6. Olympus Licenses Digital Pathology Patents to Zeiss
7. Bluechiip Licenses Its Technology in Deal with US Tech Company MiTeGen
8. Syngenta Licenses Plant Sensory Systems' Technology
9. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
10. Personal Genome Diagnostics Inc. Licenses Genome-Mapping Technology from Johns Hopkins University and Expands Its Cancer Genome Analysis Business
11. SRI International Licenses Bed Bug Detection Technology to Redcoat, a Virginia-Based Start-Up Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Mitotech S.A, a Luxembourg ... Hereditary Optic Neuropathy (LHON) patients. LHON is a rare devastating genetic disease that leads ... eye drops in a group of 20 patients carrying 11778, 14484 and 3460 mutations ...
(Date:4/27/2017)... ... April 27, 2017 , ... During the course ... how testing for 1,25-Dihydroxyvitamin D can enhance clinical practice. Participants will learn the ... dihydroxyvitamin D. , Dr. Gregory Plotnikoff, senior consultant with Minnesota Personalized Medicine, will ...
(Date:4/27/2017)... USA (PRWEB) , ... April 27, 2017 , ... ... optics and photonics , joined other scientists, researchers, engineers, and industry professionals in ... to strengthen America's ability to compete in the world photonics industry. , This ...
(Date:4/27/2017)... , April 27, 2017  Kinexum, a distinguished ... products, today announces the appointment of Thomas C. ... Alexander ("Zan") Fleming, M.D., Kinexum founder, who becomes Executive ... advisor to Kinexum clients. Thomas Seoh ... on the Kinexum mission and lead the firm,s remarkable ...
Breaking Biology Technology:
(Date:3/23/2017)... Mar. 23, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 8.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):